Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - tablet - each tablet contains lamotrigine 25,0 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - tablet - each tablet contains lamotrigine 50,0 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - tablet - see ingredients - each tablet contains simvastatin 40,0 mg

Namibie - angličtina - Namibia Medicines Regulatory Council

pharma dynamics (pty) ltd - amlodipine besylate - tablet - each tablet contains amlodipine besylate equiv. to amlodipine 5,0 mg

Namibie - angličtina - Namibia Medicines Regulatory Council

pharma dynamics (pty) ltd - amlodipine besylate - tablet - each tablet contains amlodipine besylate equiv. to amlodipine 10,0 mg

Namibie - angličtina - Namibia Medicines Regulatory Council

pharma dynamics (pty) ltd - clopidogrel hydrogen sulphate - tablet - each film-coated tablet contains clopidogrel hydrogen sulphate equivalent to clopidogrel 75,0 mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - nortriptyline hydrochloride - oral tablet - 10mg

Spojené státy - angličtina - NLM (National Library of Medicine)

clinical solutions wholesale, llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (

Spojené státy - angličtina - NLM (National Library of Medicine)

quality care products llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period

Spojené státy - angličtina - NLM (National Library of Medicine)

bryant ranch prepack - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period a